daehwa pharm co ltd (067080:KOSDAQ)
Last 8,190 KRW
Change Today -80.00 / -0.97%
Volume 354.1K
067080 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:28 AM 05/16/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Suk-Ju LeeDirector, DAE HWA Pharmaceutical Co., Ltd. |
| Age | Total Calculated Compensation | This person is connected to 8 board members in 1 different organizations across 1 different industries. See Board Relationships |
| 58 | -- |
Background*
Suk-Ju Lee served as Senior Managing Director at MEDITEL. Suk-Ju Lee serves as Director of Daehwa Pharmaceutical Co. Ltd. Suk-Ju Lee served at Boryung Pharm Co., Ltd. Suk-Ju Lee graduated in Trade at Kookmin University. .
Corporate Headquarters*Daehwa buildingSeoul, -- -- South Korea Phone: 82 2 6176 1071 Fax: 82 2 588 3111 Board Members Memberships*Director
Education*Unknown/Other Education Kookmin University
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| 067080:KS | 8,190.00 KRW | -80.00 |  |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact DAEHWA PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
